These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12827615)

  • 1. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
    Frierson HF; Moskaluk CA; Powell SM; Zhang H; Cerilli LA; Stoler MH; Cathro H; Hampton GM
    Hum Pathol; 2003 Jun; 34(6):605-9. PubMed ID: 12827615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of mesothelin immunostaining in tumor diagnosis.
    Ordóñez NG
    Am J Surg Pathol; 2003 Nov; 27(11):1418-28. PubMed ID: 14576474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.
    Lamberts LE; de Groot DJ; Bense RD; de Vries EG; Fehrmann RS
    Oncotarget; 2015 Sep; 6(29):28164-72. PubMed ID: 26172299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
    Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
    Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.
    Weidemann S; Gagelmann P; Gorbokon N; Lennartz M; Menz A; Luebke AM; Kluth M; Hube-Magg C; Blessin NC; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Izbicki JR; Jansen K; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech RH; Dum D; Krech T; Marx AH; Simon R
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of HE4 expression in normal and malignant human tissues.
    Galgano MT; Hampton GM; Frierson HF
    Mod Pathol; 2006 Jun; 19(6):847-53. PubMed ID: 16607372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
    Yen MJ; Hsu CY; Mao TL; Wu TC; Roden R; Wang TL; Shih IeM
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):827-31. PubMed ID: 16467095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.
    Muminova ZE; Strong TV; Shaw DR
    BMC Cancer; 2004 May; 4():19. PubMed ID: 15140265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
    Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
    Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
    Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
    Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
    Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression patterns in ovarian carcinomas.
    Schaner ME; Ross DT; Ciaravino G; Sorlie T; Troyanskaya O; Diehn M; Wang YC; Duran GE; Sikic TL; Caldeira S; Skomedal H; Tu IP; Hernandez-Boussard T; Johnson SW; O'Dwyer PJ; Fero MJ; Kristensen GB; Borresen-Dale AL; Hastie T; Tibshirani R; van de Rijn M; Teng NN; Longacre TA; Botstein D; Brown PO; Sikic BI
    Mol Biol Cell; 2003 Nov; 14(11):4376-86. PubMed ID: 12960427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter.
    Tan K; Kajino K; Momose S; Masaoka A; Sasahara K; Shiomi K; Izumi H; Abe M; Ohtsuji N; Wang T; Hino O; Fujii H
    Hum Pathol; 2010 Sep; 41(9):1330-8. PubMed ID: 20573372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness.
    Weidemann S; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Nahrstedt U; Jacobsen F; Bernreuther C; Simon R; Steurer S; Burandt E; Marx AH; Krech T; Clauditz TS; Jansen K
    Cancer Invest; 2021 Oct; 39(9):711-720. PubMed ID: 34143695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
    Drapkin R; Crum CP; Hecht JL
    Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
    Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
    Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.
    Alvarez H; Rojas PL; Yong KT; Ding H; Xu G; Prasad PN; Wang J; Canto M; Eshleman JR; Montgomery EA; Maitra A
    Nanomedicine; 2008 Dec; 4(4):295-301. PubMed ID: 18691948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of PAX8 expression in human epithelial tumors.
    Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
    Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
    Ritterhouse LL; Wu EY; Kim WG; Dillon DA; Hirsch MS; Sholl LM; Agoston AT; Setia N; Lauwers GY; Park DY; Srivastava A; Doyle LA
    Histopathology; 2019 Oct; 75(4):546-551. PubMed ID: 31054158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.